NIH Guide to Grants and Contracts

The NIH Guide for Grants and Contracts is our official publication for NIH grant policies, guidelines and funding opportunities. We publish daily, and issue a table of contents weekly. Learn more about the NIH Guide and subscribe today!

The old advanced search is still avaliable.

New Features:

  • Tabular view - You can now view the search results in table format.
  • Export to excel - Search results can now be exported to excel for reporting purposes.

Results: 1 to 25 of 1402

Display Results as:

NIOSH Small Research Program (R03) - PAR-12-200

Organization: NIOSH 

Posting Date: 07-25-2012 

Expiration Date: 05-18-2018 

Activity Code: R03 

Summary: The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.  

NIOSH Exploratory/Developmental Grant Program (R21) - PAR-12-252

Organization: NIOSH 

Posting Date: 07-27-2012 

Expiration Date: 05-18-2018 

Activity Code: R21 

Summary: The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.  

Occupational Safety and Health Research (R01) - PAR-13-129

Organization: NIOSH 

Posting Date: 03-01-2013 

Expiration Date: 05-08-2018 

Activity Code: R01 

Summary: The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.  

Mentored Research Scientist Development Award (K01) - PAR-13-245

Organization: NIOSH 

Posting Date: 07-03-2013 

Expiration Date: 05-18-2018 

Activity Code: K01 

Summary: The purpose of the K01 is to provide support and 75% protected time for an intensive, supervised (mentored) career development experience in occupational health and safety research leading to research independence. The goal of the NIOSH Mentored Research Scientist Development Award (K01) is to help ensure the availability of an adequate numbers of highly trained scientists and educators to address occupational safety and health critical issues.  

Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) - PA-14-038

Organization: NIDA 

Posting Date: 12-12-2013 

Expiration Date: 01-08-2018 

Activity Code: R01 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought. 

Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) - PA-14-036

Organization: NIDA 

Posting Date: 12-12-2013 

Expiration Date: 01-08-2018 

Activity Code: R21 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought.  

Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) - PA-14-037

Organization: NIDA 

Posting Date: 12-12-2013 

Expiration Date: 01-08-2018 

Activity Code: R03 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought.  

Limited Competition: Specific pathogen free macaque colonies (U42) - PAR-14-066

Organization: ORIP 

Posting Date: 01-09-2014 

Expiration Date: 01-08-2018 

Activity Code: U42 

Summary: Multiple dates, see announcement. 

Neuroimmune Signaling and Function in Substance Use Disorders (R21) - PA-14-083

Organization: NIDA 

Posting Date: 02-04-2014 

Expiration Date: 01-08-2018 

Activity Code: R21 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of grant applications that propose to examine the molecular, cellular, circuit, and behavioral responses to neuroimmune signaling within the central nervous system (CNS) as it pertains to the initiation, escalation, and maintenance of, and the neurological consequences resulting from, substance use disorders (SUDs), and to abstinence and withdrawal from, and subsequent relapse of, drug use. The goal of this understudied area of research is to determine the extent to which neuroimmune responses contribute to or protect against current and future risk and consequences of SUDs.  

Neuroimmune Signaling in Substance Use Disorders (R01) - PA-14-084

Organization: NIDA 

Posting Date: 02-04-2014 

Expiration Date: 01-08-2018 

Activity Code: R01 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of research project grant applications that propose to examine the molecular, cellular, circuit, and behavioral responses to neuroimmune signaling within the central nervous system (CNS) as it pertains to the initiation, escalation, and maintenance of, and the neurological consequences resulting from, substance use disorders (SUDs), and to abstinence and withdrawal from, and subsequent relapse of, drug use. The goal of this understudied area of research is to determine the extent to which neuroimmune responses contribute to or protect against current and future risk and consequences of SUDs.  

NEI Clinical Vision Research: Resouce Center Grant (UG1) - PAR-14-097

Organization: NEI 

Posting Date: 02-12-2014 

Expiration Date: 01-08-2018 

Activity Code: UG1 

Summary: The National Eye Institute (NEI) supports investigator-initiated clinical vision research projects, including multi-center clinical trials, human gene-transfer and stem cell therapy studies, and other complex or high-risk clinical vision research studies. These studies are typically funded as either a single grant award with multiple components (e.g., Chair's, Coordinating Center, Clinical Center, Resource Center) or as a group of linked single-component grant awards to separate institutions. This funding opportunity announcement (FOA) encourages applications for single component grant awards. Institutions interested in a multi-component grant should use the companion FOA PAR-14-096.  

NEI Clinical Vision Research: Chairman's Grant (UG1) - PAR-14-098

Organization: NEI 

Posting Date: 02-12-2014 

Expiration Date: 01-08-2018 

Activity Code: UG1 

Summary: The National Eye Institute (NEI) supports investigator-initiated clinical vision research projects, including multi-center clinical trials, human gene-transfer and stem cell therapy studies, and other complex or high-risk clinical vision research studies. These studies are typically funded as either a single grant award with multiple components (e.g., Chair's, Coordinating Center, Clinical Center, Resource Center) or as a group of linked single-component grant awards to separate institutions. This funding opportunity announcement (FOA) encourages applications for single component grant awards. Institutions interested in a multi-component grant should use the companion FOA PAR-14-096.  

NEI Clinical Vision Research: Clinical Center Grant (UG1) - PAR-14-099

Organization: NEI 

Posting Date: 02-12-2014 

Expiration Date: 01-08-2018 

Activity Code: UG1 

Summary: The National Eye Institute (NEI) supports investigator-initiated clinical vision research projects, including multi-center clinical trials, human gene-transfer and stem cell therapy studies, and other complex or high-risk clinical vision research studies. These studies are typically funded as either a single grant award with multiple components (e.g., Chair's, Coordinating Center, Clinical Center, Resource Center) or as a group of linked single-component grant awards to separate institutions. This funding opportunity announcement (FOA) encourages applications for single component grant awards. Institutions interested in a multi-component grant should use the companion PAR-14-096.  

NEI Clinical Vision Research: Coordinating Center Grant (UG1) - PAR-14-100

Organization: NEI 

Posting Date: 02-12-2014 

Expiration Date: 01-08-2018 

Activity Code: UG1 

Summary: The National Eye Institute (NEI) supports investigator-initiated clinical vision research projects, including multi-center clinical trials, human gene-transfer and stem cell therapy studies, and other complex or high-risk clinical vision research studies. These studies are typically funded as either a single grant award with multiple components (e.g., Chair's, Coordinating Center, Clinical Center, Resource Center) or as a group of linked single-component grant awards to separate institutions. This funding opportunity announcement (FOA) encourages applications for single component grant awards. Institutions interested in a multi-component grant should use the companion PAR-14-096.  

Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01) - PAR-14-106

Organization: NIDA 

Posting Date: 02-20-2014 

Expiration Date: 01-08-2018 

Activity Code: R01 

Summary: The purpose of this FOA is to support research to deepen our knowledge of the use of synthetic psychoactive drugs, their mechanisms of action, their health effects, and development of prevention strategies and strategies to treat patients in emergency departments and long range treatment.  

Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21) - PAR-14-105

Organization: NIDA 

Posting Date: 02-20-2014 

Expiration Date: 01-08-2018 

Activity Code: R21 

Summary: The purpose of this FOA is to support research to deepen our knowledge of the use of synthetic psychoactive drugs, their mechanisms of action, their health effects, and development of prevention strategies and strategies to treat patients in emergency departments and long range treatment.  

Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03) - PAR-14-104

Organization: NIDA 

Posting Date: 02-20-2014 

Expiration Date: 01-08-2018 

Activity Code: R03 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to support research to deepen our knowledge of the use of synthetic psychoactive drugs, their mechanisms of action, their health effects, and development of prevention strategies and strategies to treat patients in emergency departments and long range treatment. 

Community Partnerships to Advance Research (CPAR) (R15) - PA-14-140

Organization: NINR 

Posting Date: 03-04-2014 

Expiration Date: 01-08-2018 

Activity Code: R15 

Summary: This funding opportunity announcement encourages researchers to partner with communities using Community Engaged Research (CEnR) methodologies that will enhance relationships leading to better interventions and positive health outcomes.  

Community Partnerships to Advance Research (CPAR) (R21) - PA-14-141

Organization: NINR 

Posting Date: 03-04-2014 

Expiration Date: 01-08-2018 

Activity Code: R21 

Summary: This funding opportunity announcement seeks to encourage researchers to partner with communities using Community Engaged Research (CEnR) methodologies that will enhance relationships leading to better interventions and positive health outcomes.  

Community Partnerships to Advance Research (CPAR) (R01) - PA-14-142

Organization: NINR 

Posting Date: 03-04-2014 

Expiration Date: 01-08-2018 

Activity Code: R01 

Summary: This funding opportunity announcement (FOA) encourages researchers to partner with communities using Community Engaged Research (CEnR) methodologies that will enhance relationships leading to better interventions and positive health outcomes.  

Effects of Cannabis Use and Cannabinoids on the Developing Brain (R21) - PA-14-162

Organization: NIDA 

Posting Date: 03-26-2014 

Expiration Date: 01-08-2018 

Activity Code: R21 

Summary: This Funding Opportunity Announcement (FOA) encourages exploratory/developmental grant (R21) applications from institutions and organizations that propose to study the effects and functional consequences of cannabis and cannabinoid exposures on the developing brain, from pre-, peri-, post-natal development through young adulthood in animal models and humans. Topics of interest pertaining to this PA include, but are not limited to: molecular and cellular mechanisms of cannabis/cannabinoid effects on the developing brain; long term functional consequences of cannabis/cannabinoid exposure on learning and memory, cognitive and emotional development.  

Effects of Cannabis Use and Cannabinoids on the Developing Brain (R01) - PA-14-163

Organization: NIDA 

Posting Date: 03-26-2014 

Expiration Date: 01-08-2018 

Activity Code: R01 

Summary: This Funding Opportunity Announcement (FOA) encourages Research Project Grant (R01) applications from institutions and organizations that propose to study the effects and functional consequences of cannabis and cannabinoid exposures on the developing brain, from pre-, peri-, post-natal development through young adulthood in animal models and humans. Topics of interest pertaining to this FOA include, but are not limited to: molecular and cellular mechanisms of cannabis/cannabinoid effects on the developing brain; long term functional consequences of cannabis/cannabinoid exposure on learning and memory, cognitive and emotional development.  

Effects of Cannabis Use and Cannabinoids on the Developing Brain (R03) - PA-14-164

Organization: NIDA 

Posting Date: 03-26-2014 

Expiration Date: 01-08-2018 

Activity Code: R03 

Summary: This Funding Opportunity Announcement (FOA) encourages Small Research Grant (R03) applications from institutions and organizations that propose to study the effects and functional consequences of cannabis and cannabinoid exposures on the developing brain, from pre-, peri-, post-natal development through young adulthood in animal models and humans. Topics of interest pertaining to this PA include, but are not limited to: molecular and cellular mechanisms of cannabis/cannabinoid effects on the developing brain; long term functional consequences of cannabis/cannabinoid exposure on learning and memory, cognitive and emotional development.  

Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44) - PA-14-172

Organization: NIMH 

Posting Date: 04-04-2014 

Expiration Date: 01-06-2018 

Activity Code: R43/R44 

Summary: This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop technologies and approaches (i.e., novel ways to use new or existing technologies) that will enable researchers to study the structure and/or function of brain localized G-protein coupled receptor proteins (GPCRs) and/or potentially identify novel selective and specific agonists/antagonists to these receptor subtypes, with a focus on mental health function or dysfunction, including HIV-related neurocognitive disorders. Technologies and approaches aimed at known receptor subtypes or orphan receptors would be of potential interest to NIMH.  

Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R41/R42) - PA-14-171

Organization: NIMH 

Posting Date: 04-04-2014 

Expiration Date: 01-06-2018 

Activity Code: R41/R42 

Summary: This funding opportunity announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to develop technologies and approaches (i.e., novel ways to use new or existing technologies) that will enable researchers to study the structure and/or function of brain localized G-protein coupled receptor proteins (GPCRs) and/or potentially identify novel selective and specific agonists/antagonists to these receptor subtypes, with a focus on mental health function or dysfunction, including HIV-related neurocognitive disorders. Technologies and approaches aimed at known receptor subtypes or orphan receptors would be of potential interest to NIMH.  

Current Search

Refine Your Results

Program Announcements (PAs)

Parent Announcments Only

Requests for Applications (RFAs)

Issuing Only

All Organizations

AHRQ

CDC

DHHS

DOJ

EPA

FDA

FIC

HRSA

NASA

NCATS

NCBDDD

NCCDPHP

NCCIH

NCEH

NCHSTP

NCI

NCID

NCIPC

NCMHD

NCPHI

NCRR

NEI

NHGRI

NHLBI

NIA

NIAAA

NIAID

NIAMS

NIBIB

NICHD

NIDA

NIDCD

NIDCR

NIDDK

NIEHS

NIGMS

NIH

NIMH

NIMHD

NINDS

NINR

NIOSH

NIP

NLM

OAR

OBSSR

OD

ODP

ODS

OPHR

ORD

ORI

ORIP

ORWH

OSC

Roadmap

SAMHSA

*On or After
*On or After
(e.g. "K" for K01 or K02, K05, etc.)
Back to Top